Literature DB >> 3069135

Isoproterenol-induced panic attacks.

R Pohl1, V K Yeragani, R Balon, J M Rainey, H Lycaki, A Ortiz, R Berchou, P Weinberg.   

Abstract

Eighty-six panic disorder patients and 45 nonpsychiatric controls were infused with isoproterenol at a rate of 1 microgram/min for up to 20 min in a placebo-controlled, double-blind study. Sixty-six percent of panic disorder patients experienced panic attacks during isoproterenol infusions, compared to 16% during placebo infusions. Nine percent of control subjects panicked with isoproterenol, but none panicked with placebo. Patients were more sensitive than controls to the anxiogenic effects of isoproterenol, as measured by subject self-ratings on a panic description scale. The frequency of panic attacks induced in patients was related to the dosage of isoproterenol; 79% of the patients who received a mean of 18.5 ng/min/kg of isoproterenol panicked. The panic attacks experienced by patients during isoproterenol infusions were similar to those experienced during placebo infusions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069135     DOI: 10.1016/0006-3223(88)90224-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

Review 1.  An Active Inference Approach to Interoceptive Psychopathology.

Authors:  Martin P Paulus; Justin S Feinstein; Sahib S Khalsa
Journal:  Annu Rev Clin Psychol       Date:  2019-05-07       Impact factor: 18.561

2.  Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome.

Authors:  Ramesh K Khurana
Journal:  Clin Auton Res       Date:  2006-08-16       Impact factor: 4.435

Review 3.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

4.  Stimulant medication and postural orthostatic tachycardia syndrome: a tale of two cases.

Authors:  William P Cheshire
Journal:  Clin Auton Res       Date:  2016-03-11       Impact factor: 4.435

5.  Mood states, sympathetic activity, and in vivo beta-adrenergic receptor function in a normal population.

Authors:  Bum-Hee Yu; Eun-Ho Kang; Michael G Ziegler; Paul J Mills; Joel E Dimsdale
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

6.  Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

Authors:  M Albus; T P Zahn; A Breier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 7.  Panic disorder. Pathophysiology and drug treatment.

Authors:  M R Johnson; R B Lydiard; J C Ballenger
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

8.  Panic Anxiety in Humans with Bilateral Amygdala Lesions: Pharmacological Induction via Cardiorespiratory Interoceptive Pathways.

Authors:  Sahib S Khalsa; Justin S Feinstein; Wei Li; Jamie D Feusner; Ralph Adolphs; Rene Hurlemann
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

Review 9.  Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?

Authors:  Sahib S Khalsa; Rachel C Lapidus
Journal:  Front Psychiatry       Date:  2016-07-25       Impact factor: 4.157

10.  The Insular Cortex Dynamically Maps Changes in Cardiorespiratory Interoception.

Authors:  Mahlega S Hassanpour; W Kyle Simmons; Justin S Feinstein; Qingfei Luo; Rachel C Lapidus; Jerzy Bodurka; Martin P Paulus; Sahib S Khalsa
Journal:  Neuropsychopharmacology       Date:  2017-08-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.